GSK sets £40 billion sales target alongside £1.9 billion savings plan
GSK targets £40 billion in sales.
British multinational pharmaceutical and biotechnology company
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
Source: Wikipedia (CC BY-SA)GSK targets £40 billion in sales.
According to Huxiu, GSK will shut down its Dresden vaccine plant, which has operated for 115 years and once produced 2 million doses of flu vaccine weekly for 70 countries. The decision follows a 26% decline in sales of its traditional Fluarix and FluLaval vaccines in 2025, and the company plans to launch an mRNA flu vaccine trial in September 2026.
GSK targets £40 billion in sales.